Advertisement

U.S. markets closed

S&P 500
4,280.15
+72.88(+1.73%)
Dow 30
33,761.05
+424.38(+1.27%)
Nasdaq
13,047.19
+267.27(+2.09%)
Russell 2000
2,016.62
+41.36(+2.09%)
Crude Oil
91.88
-2.46(-2.61%)
Gold
1,818.90
+11.70(+0.65%)

Advertisement

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

41.47

+1.13

(+2.80%)

At close: 04:00PM EDT

41.55

+0.08

(+0.19%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	40.34
Open	41.16
Bid	41.50 x 1800
Ask	41.63 x 900
Day's Range	40.57 - 43.06
52 Week Range	34.88 - 277.80
Volume	5,031,602
Avg. Volume	7,493,135

Market Cap	3.244B
Beta (5Y Monthly)	1.51
PE Ratio (TTM)	N/A
EPS (TTM)	-17.51
Earnings Date	Nov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	124.60

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NVAX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Novavax, Inc.
Daily – Vickers Top Buyers & Sellers for 04/05/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
4 months agoArgus Research

All

Motley Fool
1 Robinhood Stock to Avoid Right Now
Commission-free trading platform Robinhood Markets grew in prominence helping newer investors participate in what remains one of the best ways to accumulate wealth over time. One example is Ocugen (NASDAQ: OCGN). Can Ocugen succeed in the COVID-19 vaccine market?
PR Newswire
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner, SK bioscience, has received a Post Approval Change Application approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-
- The San Joaquin County Health Department says the Novavax vaccine will soon be available
  CBS-Sacramento
- Novavax's Revenue Could Fall Even More -- and It's Actually Good News
  Motley Fool
Motley Fool
Why Novavax Stock Was Plummeting This Week
A hugely disappointing quarter and new bear takes on the company by analysts made for a very bad set of trading days.

Advertisement

S&P 5004,280.15+72.88(+1.73%)

Dow 3033,761.05+424.38(+1.27%)

Nasdaq13,047.19+267.27(+2.09%)

Russell 20002,016.62+41.36(+2.09%)

Crude Oil91.88-2.46(-2.61%)

Gold1,818.90+11.70(+0.65%)

Novavax, Inc. (NVAX)

Chart Events

Performance Outlook

Fair Value

Related Research

1 Robinhood Stock to Avoid Right Now

Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17

Why Novavax Stock Was Plummeting This Week

S&P 500
4,280.15
+72.88(+1.73%)

Dow 30
33,761.05
+424.38(+1.27%)

Nasdaq
13,047.19
+267.27(+2.09%)

Russell 2000
2,016.62
+41.36(+2.09%)

Crude Oil
91.88
-2.46(-2.61%)

Gold
1,818.90
+11.70(+0.65%)